Learn more

MERIAL LTD

Overview
  • Total Patents
    1,432
  • GoodIP Patent Rank
    10,454
  • Filing trend
    0.0%
About

MERIAL LTD has a total of 1,432 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1990. It filed its patents most often in Canada, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC, MERIAL INC and INTERVET INT BV.

Patent filings per year

Chart showing MERIAL LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Soll Mark D 96
#2 Soll Mark David 81
#3 Meng Charles Q 77
#4 Seeger Karl 71
#5 Boeckh Albert 66
#6 Knauf Werner 63
#7 Audonnet Jean-Christophe 60
#8 Maier Michael 58
#9 Schnatterer Stefan 57
#10 Bublot Michel 55

Latest patents

Publication Filing date Title
ZA201501696B Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
US2015283228A1 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
WO2015085242A1 Skin innate response linked to protective intradermal vaccination against respiratory infection
AU2014265124A1 Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
CN105992592A Haemophilus parasuis vaccine serovar type four
CN105682607A Multi-chamber, multi-formulation fluid delivery system
CN105473584A Thiophene- or furan-substituted isothiazoline compounds as pesticides
CN105473563A Isothiazoline compounds substituted with a carbobicyclic group
US2014213624A1 Method for treating and curing leishmaniosis using fexinidazole
CN104995315A High resolution melt genotyping OD IBV, CSFV and NDV
JP2014040468A Compositions comprising c-13 alkoxyether macrolide compounds and phenylpyrazole compounds
WO2014014725A1 Method of providing protective immunity against heterologous leptospira strains
AU2013206630A1 Injectable parasiticidal formulations of levamisole and macrocyclic lactones
CN104780935A Attenuated streptococcus suis vaccines and methods of making and use thereof
TN2013000210A1 Leishmania canine challenge model by sand fly bites
TW201348210A Improved processes for the preparation of 1-aryl-5-alkyl pyrazole compounds
WO2013138776A1 Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
WO2013142371A1 Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
US2014228785A1 Multi-cavity container having offset indentures for dispensing fluids
FI20145771A Parasiticidal oral veterinary compositions comprising systematically-acting active agents for treating and/or preventing a parasitic infection or infestation in an animal